Fundz

Massive Bio Raises $9 Million To Scale Growth And Fuel Global Expansion Of Its Ai-Enabled Oncology Clinical Trial Platform

PRIVATEJun 02, 2022

Amount Raised

$9 Million

Round Type

Funding Round

New YorkBiotechnologySoftwareMobileCommunity And LifestyleHealth CareArtificial Intelligence

Description

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, raised $9 million co-led by Revo Capital and Kenan Turnacioğlu, Chair of Board of Directors PaigeAI, with additional participation from DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH, the German Development Finance Institution.

Quick answer

Massive Bio and Foundation Medicine raised $9 Million in a Funding Round round, dated June 2, 2022. Massive Bio and Foundation Medicine is based in New York, New York, United States.

How much did Massive Bio and Foundation Medicine raise?
Massive Bio and Foundation Medicine raised $9 Million in a Funding Round round on June 2, 2022.
What does Massive Bio and Foundation Medicine do?
Massive Bio is a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. is a global leader in next generation sequencing (NGS) and network of healthcare providers.
Where is Massive Bio and Foundation Medicine based and how big is it?
Massive Bio and Foundation Medicine is based in New York, New York, United States. Fundz records about 90 employees.
Who are the decision-makers at Massive Bio and Foundation Medicine?
Fundz holds 2 contacts at Massive Bio and Foundation Medicine, including the Co-Founder and CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Mobile and Community And Lifestyle around the same time

Companies in the same sectors as Massive Bio and Foundation Medicine that raised within 45 days of this round, from Fundz verified event records.

  • Pictor Labs raised $7.6M on May 27, 2022.
  • Sequentify raised $7M (Funding Round) on May 10, 2022.
  • IMPLICITY raised $23M (Funding Round) on April 27, 2022.
  • Biofourmis raised an undisclosed amount on April 26, 2022.
  • PMGC Holdings Inc. raised $2.1M (Seed) on July 15, 2022.
  • Nucleus Genomics raised $18M (Funding Round) on July 14, 2022.

Who to call at Massive Bio and Foundation Medicine, and when

A new round usually means Massive Bio and Foundation Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Massive Bio and Foundation Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Massive Bio and Foundation Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Massive Bio and Foundation Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Massive Bio and Foundation Medicine

Location

New York, New York, United States

About

Massive Bio is a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. is a global leader in next generation sequencing (NGS) and network of healthcare providers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Massive Bio and Foundation Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSelin K., Co-Founder and CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Massive Bio and Foundation Medicine's next move

See what Strategic adds

Massive Bio and Foundation Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.